Hideshima, Teru
Ogiya, Daisuke
Liu, Jiye
Harada, Takeshi
Kurata, Keiji
Bae, Jooeun
Massefski, Walter
Anderson, Kenneth C.
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (R01-CA178264)
Article History
Received: 5 November 2019
Revised: 17 March 2020
Accepted: 18 March 2020
First Online: 1 April 2020
Compliance with ethical standards
:
: KCA serves on advisory boards to Celgene, Millennium, Janssen, Sanofi, Bristol Myers Squibb, Gilead, Precision Biosciences, and Tolero, and is a Scientific Founder of OncoPep and C4 Therapeutics. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the paper apart from those disclosed.